TA
GWPH

Tamarack Advisers’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Tamarack Advisers’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-90,000
Closed -$11M – 44
2020
Q2 		$11M Buy
+90,000
New +$10.2M 3.08% 15
2019
Q4 		– Sell
-25,000
Closed -$2.88M – 36
2019
Q3 		$2.88M Buy
+25,000
New +$3.79M 0.75% 24

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Tamarack Advisers's GWPH Position: Q3 2020 in Review

Tamarack Advisers sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2020, closing a stake of 90,000 shares — an estimated $11M sold.

Tamarack Advisers first reported a position in GWPH in Q3 2019 and held it in 2 quarters. The position peaked at $11M in Q2 2020. 279 funds tracked by Wall St. Rank hold GWPH as of Q3 2020.

  • Tamarack Advisers reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2020 after selling out during the quarter.
  • Tamarack Advisers sold 90,000 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2020, an estimated $11M.
  • Tamarack Advisers first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2019 and held it in 2 quarters.
  • Tamarack Advisers's GW Pharmaceuticals Plc American Depositary Shares position peaked at $11M in Q2 2020.
  • 279 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2020.

Based on Tamarack Advisers's 13F filing for Q3 2020, filed 12 Nov 2020.